GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

111 hedge funds and large institutions have $824M invested in Genomic Health, Inc. in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 8 closing their positions.

Holders
111
Holders Change
-4
Holders Change %
-3.48%
% of All Funds
3.6%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
39
Reduced
38
Closed
8
Calls
$992K
Puts
$1.23M
Net Calls
-$235K
Net Calls Change
+$3.08M
Name Market Value Shares Shares
Change
Shares
Change %
BlackRock
101
BlackRock
New York
$14K 472 +59 +14%
FHA
102
First Horizon Advisors
Tennessee
$12K 385
TRCT
103
Tower Research Capital (TRC)
New York
$9K 305 -3,868 -93%
CCM
104
Credo Capital Management
Maryland
$9K 307
TCOV
105
Trust Company of Vermont
Vermont
$9K 285
WA
106
WFG Advisors
Texas
$8K 250 -250 -50%
JIC
107
Joel Isaacson & Co
New York
$6K 200
Group One Trading
108
Group One Trading
Illinois
$5K 178 -6,200 -97%
TWA
109
TCI Wealth Advisors
Arizona
$5K 160
RFC
110
Russell Frank Company
Washington
$3K 85 -15 -15%
Manulife (Manufacturers Life Insurance)
111
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$403 13,159 -411 -3%
Two Sigma Investments
112
Two Sigma Investments
New York
-89,912 Closed
GC
113
Guggenheim Capital
Illinois
-72,263 Closed
Allianz Asset Management
114
Allianz Asset Management
Germany
-29,200 Closed
Nomura Holdings
115
Nomura Holdings
Japan
-17,752 Closed
D.E. Shaw & Co
116
D.E. Shaw & Co
New York
-7,500 Closed
QBFM
117
QS Batterymarch Financial Management
New York
-5,300 Closed
MCM
118
Matarin Capital Management
New York
-2,376 Closed
OWP
119
Obermeyer Wealth Partners
Colorado
-130 Closed
PCM
120
Prelude Capital Management
New York
WMSA
121
Weiss Multi-Strategy Advisers
New York
Susquehanna International Group
122
Susquehanna International Group
Pennsylvania